33
/pt/
AIzaSyB4mHJ5NPEv-XzF7P6NDYXjlkCWaeKw5bc
November 1, 2025
3512550
319423
2
Public Timelines
FAQ Receber premium

1 jan 1997 ano - Rituximab

Descrição:

For use in patients with treatment-resistant, low-grade or follicular B-cell non-Hodgkin lymphoma (NHL), the Food and Drug Administration (FDA) approves rituximab, a monoclonal antibody.

Adicionado na linha do tempo:

14 nov 2019
0
0
299

Data:

1 jan 1997 ano
Agora
~ 28 years ago